607 related articles for article (PubMed ID: 15743351)
1. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
2. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
3. Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus.
Chwiesko A; Baniukiewicz A; Semeniuk J; Kaczmarski M; Wasielica-Berger J; Milewski R; Dabrowski A
Dis Esophagus; 2015; 28(6):585-92. PubMed ID: 24867362
[TBL] [Abstract][Full Text] [Related]
4. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
[TBL] [Abstract][Full Text] [Related]
5. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
7. The biopsy diagnosis of gastroesophageal reflux disease, "carditis," and Barrett's esophagus, and sequelae of therapy.
Riddell RH
Am J Surg Pathol; 1996; 20 Suppl 1():S31-50. PubMed ID: 8694147
[TBL] [Abstract][Full Text] [Related]
8. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
[TBL] [Abstract][Full Text] [Related]
9. GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus.
Souza RF; Lunsford T; Ramirez RD; Zhang X; Lee EL; Shen Y; Owen C; Shay JW; Morales C; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G19-24. PubMed ID: 17395902
[TBL] [Abstract][Full Text] [Related]
10. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
11. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
13. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
Brandt MG; Darling GE; Miller L
Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
15. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
16. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
Souza RF; Krishnan K; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
[TBL] [Abstract][Full Text] [Related]
17. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
18. Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.
Ostrowski J; Mikula M; Karczmarski J; Rubel T; Wyrwicz LS; Bragoszewski P; Gaj P; Dadlez M; Butruk E; Regula J
J Mol Med (Berl); 2007 Jul; 85(7):733-43. PubMed ID: 17415542
[TBL] [Abstract][Full Text] [Related]
19. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
